Castle Creek Biosciences has a total of 98 patents globally, out of which 18 have been granted. Of these 98 patents, 7% patents are active. United States Of America is where Castle Creek Biosciences has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Castle Creek Biosciences.
Castle Creek Biosciences was founded in 2018 by Jeff Aronin. Castle Creek Biosciences operates as a gene therapy company. The Company focuses on delivering transformative therapies for patients living with rare and serious diseases with high unmet needs. Castle Creek Biosciences serves customers in the United States.
Do read about some of the most popular patents of Castle Creek Biosciences which have been covered by us in this article and also you can find Castle Creek Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Castle Creek Biosciences patent portfolio.
How many patents does the CEO of Castle Creek Biosciences have?
The CEO, Matthew Gantz has 0 patents.
How many patents does Castle Creek Biosciences have?
Castle Creek Biosciences has a total of 98 patents globally. These patents belong to 16 unique patent families. Out of 98 patents, 7 patents are active.
How Many Patents did Castle Creek Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Castle Creek Biosciences Applications Filed | Castle Creek Biosciences Patents Granted |
| 2011 | 11 | – |
| 2012 | 1 | – |
| 2013 | 12 | – |
| 2015 | 2 | – |
| 2017 | 1 | – |
| 2018 | 1 | – |
| 2019 | – | 3 |
| 2021 | – | 1 |
How many Castle Creek Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Castle Creek Biosciences File in Different Countries?
Countries in which Castle Creek Biosciences Filed Patents
| Country | Patents |
| United States Of America | 11 |
| Europe | 10 |
| Japan | 9 |
| Hong Kong (S.A.R.) | 8 |
| Korea (South) | 6 |
| Canada | 6 |
| Mexico | 5 |
| China | 5 |
| Australia | 5 |
| Brazil | 3 |
| Malaysia | 2 |
| Taiwan | 2 |
| Argentina | 2 |
| Chile | 2 |
| Germany | 2 |
| Portugal | 1 |
| Austria | 1 |
| Israel | 1 |
| India | 1 |
| Spain | 1 |
| New Zealand | 1 |
| Denmark | 1 |
Where are Research Centers of Castle Creek Biosciences Patents Located?
10 Best Castle Creek Biosciences Patents
US20040101959A1 is the most popular patent in the Castle Creek Biosciences portfolio. It has received 114 citations so far from companies like Warsaw Orthopedic and Allergan.
Below is the list of 10 most cited patents of Castle Creek Biosciences:
| Publication Number | Citation Count |
| US20040101959A1 | 114 |
| US20070207131A1 | 45 |
| WO2008027984A1 | 31 |
| EP1358857A1 | 30 |
| US20130236427A1 | 22 |
| US20030147831A1 | 22 |
| US20040013652A1 | 21 |
| EP1421957A1 | 21 |
| US7186557B2 | 18 |
| US20060182725A1 | 16 |
What Percentage of Castle Creek Biosciences US Patent Applications were Granted?
Castle Creek Biosciences (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 72.73%.
Below are the key stats of Castle Creek Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Castle Creek Biosciences?
| Law Firm | Total Applications | Success Rate |
| Stradley Ronon Fibrocell | 14 | 72.73% |
EXCLUSIVE INSIGHTS COMING SOON!